Asia breast cancer screening market size is expected to cross over US$ 4 Billion by 2022. China, Japan and Korea are the top most contributors. Increasing breast cancer awareness, government and NGOs support breast cancer screening programs and ageing women population are major driving forces for this market. Key threats for breast cancer market in Asia are societal fear, misconceptions and cultural barriers for Breast Cancer Screening. Other major challenge being faced by almost all Asian countries is non availability of national level screening program; however partial or regional screening programs are available in few of these countries.
Download full Report: http://www.renub.com/asia-breast-cancer-screening-market-forecast-mammography-mri-and-ultrasound-1122-p.php